Trade

with

Oculus Innovative Sciences Inc
(NASDAQ: OCLS)
AdChoices
2.00
+0.04
+1.89%
After Hours :
1.85
-0.15
-7.36%

Open

1.92

Previous Close

1.96

Volume (Avg)

62.35k (59.80k)

Day's Range

1.80-2.02

52Wk Range

1.66-7.21

Market Cap.

16.93M

Dividend Rate ( Yield )

-

Beta

1.03

Shares Outstanding

8.48M

P/E Ratio (EPS)

2.72 (0.73)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 13.67M

    • Net Income

    • 3.74M

    • Market Cap.

    • 16.93M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 39.28

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.03

    • Forward P/E

    • -4.26

    • Price/Sales

    • 1.05

    • Price/Book Value

    • 1.24

    • Price/Cash flow

    • -2.48

      • EBITDA

      • 5.08M

      • Return on Capital %

      • 35.31

      • Return on Equity %

      • 67.12

      • Return on Assets %

      • 35.31

      • Book Value/Share

      • 1.58

      • Shares Outstanding

      • 8.48M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 7.50

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -0.46

        • Cashflow Estimate

        • 0.11

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.60

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • -

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 20.46

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 59.20

            • 64.72

            • Pre-Tax Margin

            • 39.28

            • 13.77

            • Net Profit Margin

            • 39.28

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 63.00

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • -53.10

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.00

              • 0.33

              • Current Ratio

              • 1.52

              • 1.52

              • Quick Ratio

              • 1.22

              • 0.87

              • Interest Coverage

              • 7.63

              • 6.77

              • Leverage Ratio

              • 1.48

              • 1.91

              • Book Value/Share

              • 1.58

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 2.39

                • 63.69

                • P/E Ratio 5-Year High

                • 30.54

                • 237.47

                • P/E Ratio 5-Year Low

                • 2.26

                • 19.71

                • Price/Sales Ratio

                • 0.94

                • 3.64

                • Price/Book Value

                • 1.11

                • 3.39

                • Price/Cash Flow Ratio

                • -2.48

                • 21.79

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 67.12

                        (-495.20)

                      • 7.86

                        (9.58)

                      • Return on Assets %

                        (5-Year Average)

                      • 35.31

                        (-63.90)

                      • 4.14

                        (5.54)

                      • Return on Capital %

                        (5-Year Average)

                      • 70.97

                        (-112.90)

                      • 5.59

                        (7.66)

                      • Income/Employee

                      • 52.72k

                      • 27.79k

                      • Inventory Turnover

                      • 5.27

                      • 1.80

                      • Asset Turnover

                      • 0.90

                      • 0.38

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -6.05M
                      Operating Margin
                      -44.27
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -2.48
                      Ownership

                      Institutional Ownership

                      15.44%

                      Top 10 Institutions

                      17.35%

                      Mutual Fund Ownership

                      3.23%

                      Float

                      99.70%

                      5% / Insider Ownership

                      36.71%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        145,980

                      • 0.00

                      • 1.72

                      • Vanguard Extended Market Index Fund

                      •  

                        76,561

                      • 0.00

                      • 0.90

                      • Vanguard Instl Total Stock Market Index

                      •  

                        23,597

                      • 0.00

                      • 0.28

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        18,447

                      • 0.00

                      • 0.22

                      • Perkins Discovery Fund

                      •  

                        7,142

                      • 0.00

                      • 0.08

                      • Fidelity® Nasdaq Composite Tr Stk Fund

                      •  

                        886

                      • 9.38

                      • 0.01

                      • Dimensional US Sm Company

                      •  

                        371

                      • 0.00

                      • 0.00

                      • Vanguard US Equity Index

                      •  

                        342

                      • 0.00

                      • 0.00

                      • Wilshire 5000 Index Portfolio

                      •  

                        128

                      • 0.00

                      • 0.00

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Sabby Management LLC

                      •  

                        495,800

                      • -86.62%

                      • 6.85

                      • Vanguard Group, Inc.

                      •  

                        246,480

                      • 0.00%

                      • 2.91

                      • National Asset Management, Inc.

                      •  

                        43,253

                      • -19.68%

                      • 0.51

                      • Geode Capital Management, LLC

                      •  

                        19,257

                      • -0.20%

                      • 0.23

                      • Bard Associates Inc

                      •  

                        19,184

                      • -90.25%

                      • 0.23

                      • Perkins Capital Management Inc

                      •  

                        7,142

                      • 0.00%

                      • 0.08

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Specific & Generic

                      Type

                      Speculative Growth

                      Style

                      Small Core

                      Oculus Innovative Sciences Inc was incorporated under the laws of the State of California in April 1999 as Micromed Laboratories, Inc. In August 2001, it changed its name to Oculus Innovative Sciences, Inc. In December 2006, it reinc...moreorporated under the laws of the State of Delaware. The Company develops, manufactures and markets a family of tissue care products that cure infections and, through a separate mechanism of action, enhance healing while reducing the need for antibiotics. Infection is a serious potential complication in both chronic and acute wounds, and controlling infection is a critical step in wound healing. The Company’s platform technology, called Microcyn(r), is a proprietary solution of electrically charged oxychlorine small molecules designed to treat a wide range of organisms tha...moret cause disease (pathogens). These include viruses, fungi, spores and antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococcus aureus, or MRSA, and vancomycin-resistant Enterococcus, or VRE, in wounds, as well as Clostridium difficile (C. diff), a highly contagious bacteria spread by human contact. The Company’s products compete with a variety of products used for wound cleaning, debriding and moistening, including sterile saline, and chlorhexadine-based products, and they also compete with a large number of prescription and over-the-counter products for the prevention and treatment of infections, including topical anti-infectives, such as Betadine, silver sulfadiazine, hydrogen peroxide, Dakin’s solution and hypochlorous acid, and topical antibiotics, such as Neosporine, Mupirocin and Bacitracin. Government authorities in the United States at the federal, state and local levels and foreign countries extensively regulate, among other things, the research, development, testing, manufacture, labeling, promotion, advertising, distribution, sampling, marketing, and import and export of pharmaceutical products, biologics and medical devices.lessless

                      Key People

                      Mr. James Schutz

                      CEO/Director/President

                      Mr. Robert Miller

                      CFO/COO/Chief Accounting Officer/Secretary

                      Bruce Thornton

                      Executive VP, Divisional

                      Dr. Jay Edward Birnbaum

                      Director

                      Sharon Surrey-Barbari

                      Director

                      • Oculus Innovative Sciences Inc

                      • 1129 North McDowell Boulevard

                      • Petaluma, CA 94954

                      • USA.Map

                      • Phone: +1 707 283-0550

                      • Fax: +1 708 283-0551

                      • oculusis.com

                      Incorporated

                      1999

                      Employees

                      102

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: